<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE230nnn/GSE230328/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230328</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>BRD8 is a therapeutic vulnerability for overcoming resistance to dual ER/HER2 blockade therapy in HR+/HER2+ breast cancer</name><description>This SuperSeries is composed of the SubSeries listed below.</description><dates><publication>2026/03/19</publication></dates><accession>GSE230328</accession><cross_references><GSM>GSM7213901</GSM><GSM>GSM7213912</GSM><GSM>GSM7213913</GSM><GSM>GSM7213902</GSM><GSM>GSM7213914</GSM><GSM>GSM7213903</GSM><GSM>GSM7213904</GSM><GSM>GSM7213915</GSM><GSM>GSM7213910</GSM><GSM>GSM7213900</GSM><GSM>GSM7213911</GSM><GSM>GSM7213909</GSM><GSM>GSM7213905</GSM><GSM>GSM7213906</GSM><GSM>GSM7213907</GSM><GSM>GSM7213908</GSM><GPL>20301</GPL><GPL>24676</GPL><GSE>230328</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>